LIGAND PHARMACEUTICALS INCORPORATED Increase (Decrease) in Other Operating Liabilities
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Increase (Decrease) in Other Operating Liabilities of $34.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2015-02-23
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating liabilities for the quarter ending 2013-12-31 was $5.00K, a 98.93% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating liabilities for the quarter ending 2013-09-30 was $17.00K.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating liabilities for the quarter ending 2013-06-30 was -$293.00K.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating liabilities for the quarter ending 2013-03-31 was -$120.00K.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating liabilities for fiscal 2014 was $34.00K.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating liabilities for fiscal 2013 was -$391.00K, a 180.79% decline from fiscal 2012.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating liabilities for fiscal 2012 was $484.00K, a 44.05% decline from fiscal 2011.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating liabilities for fiscal 2011 was $865.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | $34.00K 10-K · filed 2015-02-23 | -$391.00K 10-K · filed 2014-12-01 | |||
| 2013-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $22.00K derived: sum of 2 quarters · filed 2015-02-23 | -$271.00K derived: sum of 3 quarters · filed 2015-02-23 | -$391.00K 10-K · filed 2015-02-23 | |
| 2013-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$276.00K derived: sum of 2 quarters · filed 2013-11-08 | -$396.00K 10-Q · filed 2013-11-08 | $73.00K derived: sum of 4 quarters · filed 2015-02-23 | |
| 2013-06-30 | -$293.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$413.00K 10-Q · filed 2013-08-01 | $56.00K derived: sum of 3 quarters · filed 2015-02-23 | ||
| 2013-03-31 | -$120.00K 10-Q · filed 2013-05-08 | $349.00K derived: sum of 2 quarters · filed 2015-02-23 | |||
| 2012-12-31 | $469.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $484.00K 10-K · filed 2015-02-23 | |||
| 2012-09-30 | $15.00K 10-Q · filed 2013-11-08 | ||||
| 2011-12-31 | $4.99M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | $2.50M derived: sum of 2 quarters · filed 2014-12-12 | $1.67M derived: sum of 3 quarters · filed 2014-12-12 | $865.00K 10-K/A · filed 2014-12-12 | |
| 2011-09-30 | -$2.49M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | -$3.33M derived: sum of 2 quarters · filed 2012-11-14 | -$4.13M 10-Q · filed 2012-11-14 | -$3.77M derived: sum of 4 quarters · filed 2013-03-14 | |
| 2011-06-30 | -$836.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-11-14 | -$1.64M 10-Q/A · filed 2012-11-14 | -$1.28M derived: sum of 3 quarters · filed 2013-03-14 | -$1.30M derived: sum of 4 quarters · filed 2013-03-14 | |
| 2011-03-31 | -$800.00K 10-Q/A · filed 2012-11-14 | -$440.00K derived: sum of 2 quarters · filed 2013-03-14 | -$460.00K derived: sum of 3 quarters · filed 2013-03-14 | ||
| 2010-12-31 | $360.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-14 | $340.00K derived: sum of 2 quarters · filed 2013-03-14 | -$715.00K 10-K · filed 2013-03-14 | ||
| 2010-09-30 | -$20.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-02-10 | -$1.07M 10-Q/A · filed 2012-02-10 | |||
| 2010-06-30 | -$1.05M 10-Q/A · filed 2012-02-10 | ||||
| 2009-12-31 | -$2.32M 10-K/A · filed 2012-11-14 |